TP53 and cancer: On the contrary, a meta-analysis study based on 18,718 cases and 21,261 controls showed that the TP53 Arg72Pro polymorphism is associated with an increased risk of cancer in Asians and Caucasian Americans only and is not associated with cancer risk in other populations [25].